Immune response to the severe acute respiratory syndrome coronavirus 2 vaccines: Is it sustained in the diabetes population?
J Diabetes Investig
.
2022 Aug;13(8):1461-1462.
doi: 10.1111/jdi.13787.
Epub 2022 Mar 25.
Authors
Erasmia Rouka
1
,
Eleni Livanou
1
,
Sotirios Sinis
1
,
Ilias Dimeas
1
,
Ioannis Pantazopoulos
1
,
Dimitrios Papagiannis
2
,
Foteini Malli
2
,
Ourania Kotsiou
2
,
Konstantinos I Gourgoulianis
1
Affiliations
1
Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Larissa, Greece.
2
Faculty of Nursing, University of Thessaly, Larissa, Greece.
PMID:
35333005
PMCID:
PMC9114921
DOI:
10.1111/jdi.13787
No abstract available
Publication types
Letter
MeSH terms
COVID-19* / prevention & control
Diabetes Mellitus*
Humans
Immunity
SARS-CoV-2
Vaccines*
Substances
Vaccines